Bioinformatics Advance Access originally published online on February 3, 2007
Bioinformatics 2007 23(8):957-965; doi:10.1093/bioinformatics/btm033
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disease-specific genomic analysis: identifying the signature of pathologic biology
1Department of Surgery, Stanford University School of Medicine, 2Department of Mathematics, 3Department of Health, Research & Policy, 4Department of Statistics, Stanford University, 5Department of Genetics, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Center and 6Medical Faculty, University of Oslo, Oslo, Norway
*To whom correspondence should be addressed.
| Abstract |
|---|
Motivation: Genomic high-throughput technology generates massive data, providing opportunities to understand countless facets of the functioning genome. It also raises profound issues in identifying data relevant to the biology being studied.
Results: We introduce a method for the analysis of pathologic biology that unravels the disease characteristics of high dimensional data. The method, disease-specific genomic analysis (DSGA), is intended to precede standard techniques like clustering or class prediction, and enhance their performance and ability to detect disease. DSGA measures the extent to which the disease deviates from a continuous range of normal phenotypes, and isolates the aberrant component of data. In several microarray cancer datasets, we show that DSGA outperforms standard methods. We then use DSGA to highlight a novel subdivision of an important class of genes in breast cancer, the estrogen receptor (ER) cluster. We also identify new markers distinguishing ductal and lobular breast cancers. Although our examples focus on microarrays, DSGA generalizes to any high dimensional genomic/proteomic data.
Contact: ssj{at}standford.edu
Supplementary information: Supplementary data are available at Bioinformatics online.
Associate Editor: Joaquin Dopazo
Received on May 9, 2006; revised on December 22, 2006; accepted on January 28, 2007
This article has been cited by other articles:
![]() |
B. A. Teicher Newer Cytotoxic Agents: Attacking Cancer Broadly Clin. Cancer Res., March 15, 2008; 14(6): 1610 - 1617. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, D. M. Ikeda, B. Narasimhan, T. A. Longacre, R. J. Bleicher, S. Pal, R. J. Jackman, and S. S. Jeffrey Estrogen Receptor-Negative Invasive Breast Cancer: Imaging Features of Tumors with and without Human Epidermal Growth Factor Receptor Type 2 Overexpression Radiology, February 1, 2008; 246(2): 367 - 375. [Abstract] [Full Text] [PDF] |
||||

